ERCC6 Sequencing

Mutations in the excision-repair cross-complementing-6 and 8 (ERCC6 and ERCC8) genes cause Cockayne syndrome type B (CSB) and type A (CSA) respectively. CSB is more common than CSA. Approximately 75% of cases of Cockayne syndrome are due to mutations in the CSB/ERCC6 gene, and most of the remaining 25% are due to mutations in the CSA/ERCC8 gene. A small number of cases are due to a deletion/duplication in either the ERCC6 or ERCC8 gene. This laboratory performs both Sanger sequencing and deletion/duplication by MLPA for both genes.

Forms & Docs

Ordering

Place an order

Test Code
S0161

Turn Around Time
6-8 weeks

 

 

Billing

CPT Code
81479×1

Ordering Guidance

Most commonly caused by sequence variants in the ERCC6 gene followed by sequence variants in the ERCC8 gene. Deletion/duplication is a less common mechanism. It is recommended to begin with ERCC6 sequencing. If negative, continue to ERCC8 sequencing. If negative, continue on to ERCC6 and ERCC8 deletion/duplication

If there are questions regarding this test, please contact Client Services at 617-553-5880 or clientservices@claritasgenomics.com

Details

Genes Covered
ERCC6 , ERCC8

Methods
Sanger